What is the share price of Max India Ltd (MAXIND) today?
The share price of MAXIND as on 27th July 2026 is ₹184.96. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Max India Ltd (MAXIND) share?
The past returns of Max India Ltd (MAXIND) share are- Past 1 week: 11.42%
- Past 1 month: 14.88%
- Past 3 months: 17.61%
- Past 6 months: 26.26%
- Past 1 year: -12.53%
- Past 3 years: 21.20%
- Past 5 years: 170.05%
What are the peers or stocks similar to Max India Ltd (MAXIND)?
The peers or stocks similar to Max India Ltd (MAXIND) include:What is the market cap of Max India Ltd (MAXIND) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Max India Ltd (MAXIND) is ₹1023.50 Cr as of 27th July 2026.What is the 52 week high and low of Max India Ltd (MAXIND) share?
The 52-week high of Max India Ltd (MAXIND) is ₹241.57 and the 52-week low is ₹120.What is the PE and PB ratio of Max India Ltd (MAXIND) stock?
The P/E (price-to-earnings) ratio of Max India Ltd (MAXIND) is -8.40. The P/B (price-to-book) ratio is 2.85.Which sector does Max India Ltd (MAXIND) belong to?
Max India Ltd (MAXIND) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Max India Ltd (MAXIND) shares?
You can directly buy Max India Ltd (MAXIND) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Max India Ltd
MAXIND Share Price
NSEMAXIND Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MAXIND Performance & Key Metrics
MAXIND Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -8.40 | 2.85 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.74 | 5.90 | 0.53% |
MAXIND Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
MAXIND Company Profile
Max India Limited operates in the health and allied services space. The Company’s operating businesses include: Max Healthcare Institute Limited, Max Bupa Health Insurance Company Limited, Antara Senior Living Limited and Max SkillFirst Limited.
MAXIND Sentiment Analysis
MAXIND Sentiment Analysis
MAXIND Stock Summary · June 2026
Strong top‑line growth paired with a disciplined push toward profitability was management's central message: consolidated FY26 revenue rose 30% to INR 213.4 crore while the consolidated EBITDA loss narrowed to INR 83 crore, reflecting sequential improvement. Management struck a measured, operational tone, prioritizing margin improvement, disciplined capital allocation and scaling high‑return real‑estate and senior‑living assets while continuing investment in AGEasy and care homes. They highlighted operational progress — handovers and services starting at Noida, fully sold and high‑collection Gurgaon phases, and Antara’s improving site‑level contribution margins — but acknowledged clear tension between rapid revenue expansion and ongoing profitability drag from growth investments, payroll and new labour‑code costs, plus lumpy receivables from project billing. Capital posture remains cautious: treasury balances and net worth underpin near‑term liquidity, they will avoid dilutive funding until market sentiment improves and plan targeted equity deployment into care homes and senior‑living projects. Near term, management expects Phase‑2 planning/launch in FY27 subject to approvals, Antara breakeven around H1 FY28 and AGEasy to reach EBITDA breakeven by year‑end.
MAXIND Stock Growth Drivers
MAXIND Stock Growth Drivers
5Material improvement in consolidated financials and clear path to profitability
The company delivered meaningful financial progress in FY26 with consolidated revenue up 30% year‑on‑year to
Real‑estate monetization, receipts and a large development pipeline
Tangible value has been unlocked in the residential pipeline with Noida authorities issuing a partial
MAXIND Stock Challenges
MAXIND Stock Challenges
8Geopolitical and macro-regulatory headwinds slowing demand and operating conditions
The company is facing a material slowdown driven by recent geopolitical disruption in India and
Rising labor costs and wage-related margin pressure
Regulatory changes to the Labour Code and recent minimum wage revisions have begun to translate
MAXIND Forecast
MAXIND Forecasts
MAXIND
MAXIND
Income
Balance Sheet
Cash Flow
MAXIND Income Statement
MAXIND Income Statement
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 45.21 | 49.68 | 32.95 | 48.23 | 39.64 | 45.47 | 49.22 | 50.17 | 49.81 | 72.04 | ||||||||||
| Operating & Other expenses | 59.39 | 67.01 | 55.89 | 65.62 | 79.02 | 85.52 | 68.11 | 80.26 | 85.14 | 83.60 | ||||||||||
| EBITDA | -14.18 | -17.33 | -22.94 | -17.39 | -39.38 | -40.05 | -18.89 | -30.09 | -35.33 | -11.56 | ||||||||||
| Depreciation/Amortization | 2.43 | 2.98 | 3.93 | 4.61 | 5.03 | 5.25 | 5.77 | 5.94 | 6.09 | 7.30 | ||||||||||
| PBIT | -16.61 | -20.31 | -26.87 | -22.00 | -44.41 | -45.30 | -24.66 | -36.03 | -41.42 | -18.86 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -16.61 | -20.31 | -26.87 | -22.00 | -44.41 | -45.30 | -24.66 | -36.03 | -41.42 | -18.86 | ||||||||||
| Taxes & Other Items | 1.29 | 1.26 | 0.10 | 0.73 | 0.19 | 0.79 | 0.98 | -1.96 | 1.43 | 0.43 | ||||||||||
| Net Income | -17.90 | -21.57 | -26.97 | -22.73 | -44.60 | -46.09 | -25.64 | -34.07 | -42.85 | -19.29 | ||||||||||
| EPS | -3.92 | -4.72 | -5.90 | -4.98 | -9.47 | -10.08 | -5.44 | -6.52 | -8.17 | -3.67 |
MAXIND Company Updates
Investor Presentation
MAXIND Stock Peers
MAXIND Past Performance & Peer Comparison
MAXIND Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Max India Ltd | -8.40 | 2.85 | — |
| Apollo Hospitals Enterprise Ltd | 65.21 | 11.41 | 0.23% |
| Max Healthcare Institute Ltd | 72.90 | 9.78 | 0.19% |
| Fortis Healthcare Ltd | 68.75 | 7.04 | 0.11% |
MAXIND Stock Price Comparison
Compare MAXIND with any stock or ETFMAXIND Holdings
MAXIND Shareholdings
MAXIND Promoter Holdings Trend
MAXIND Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
MAXIND Institutional Holdings Trend
MAXIND Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
MAXIND Shareholding Pattern
MAXIND Shareholding Pattern
MAXIND Shareholding History
MAXIND Shareholding History
smallcases containing MAXIND stock
smallcases containing MAXIND stock
Looks like this stock is not in any smallcase yet.
MAXIND Events
MAXIND Events
MAXIND Dividend Trend
MAXIND has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
MAXIND Dividend Trend
MAXIND has not given any dividends in last 5 years
MAXIND Dividends
MAXIND Dividends
MAXIND Stock News & Opinions
MAXIND Stock News & Opinions
Max India announced that the 7th Annual General Meeting(AGM) of the company will be held on 19 August 2026.
Net Loss of Max India reported to Rs 19.29 crore in the quarter ended March 2026 as against net loss of Rs 46.09 crore during the previous quarter ended March 2025. Sales rose 58.07% to Rs 65.63 crore in the quarter ended March 2026 as against Rs 41.52 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 121.85 crore in the year ended March 2026 as against net loss of Rs 140.39 crore during the previous year ended March 2025. Sales rose 30.98% to Rs 190.56 crore in the year ended March 2026 as against Rs 145.49 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales65.6341.52 58 190.56145.49 31 OPM %-22.87-98.31 --57.63-81.23 - PBDT-11.36-39.70 71 -100.65-106.81 6 PBT-18.66-44.95 58 -125.75-125.63 0 NP-19.29-46.09 58 -121.85-140.39 13 Powered by Capital Market - Live
Max India will hold a meeting of the Board of Directors of the Company on 28 May 2026.
Net Loss of Max India reported to Rs 42.85 crore in the quarter ended December 2025 as against net loss of Rs 44.60 crore during the previous quarter ended December 2024. Sales rose 24.06% to Rs 43.10 crore in the quarter ended December 2025 as against Rs 34.74 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales43.1034.74 24 OPM %-82.88-85.32 - PBDT-32.46-26.78 -21 PBT-38.55-31.81 -21 NP-42.85-44.60 4 Powered by Capital Market - Live
Max India will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live
Max India has allotted 12,500 equity shares under ESOP on 09 January 2026. Consequent to the aforesaid allotment, the issued, subscribed and paid-up capital of the Company stand increased from Rs 52,45,03,620 (comprising of 5,24,50,362 equity shares of of Rs 10/- each) to Rs.52,46,28,620 (comprising of 5,24,62,862 equity shares of Rs 10/- each).Powered by Capital Market - Live
AGEasy, the consumer products brand under Antara Senior Care'India's most comprehensive and integrated senior-care ecosystem'today announced the launch of its specialised Gut Care Range, developed in partnership with Wellbeing Nutrition, a leader in clean-label, science-backed nutraceuticals. Speaking about the launch, Ishaan Khanna, CEO, Antara Assisted Care Services, said, 'Gut health is foundational for seniors. Scientific literature shows that it influences immunity, inflammation, metabolic parameters and even cognitive function. With AGEasy's understanding of senior needs and Wellbeing Nutrition's scientific rigor, we have created a range that addresses the unique requirements of the ageing gut. The AGEasy Gut Care Range provides sustained, reliable support for concerns like acidity, constipation, bloating and overall digestive balance. At AGEasy, our mission is to enable self-care that is effortless, effective and joyful for seniors.'Powered by Capital Market - Live
Max India has allotted 20,000 equity shares under ESOP on 12 December 2025. Consequent to the aforesaid allotment, the issued, subscribed and paid-up capital of the Company stand increased from Rs. 52,43,03,620 (consisting of 5,24,30,362 equity shares of face value of Rs 10 each) to Rs 52,45,03,620 (consisting of 5,24,50,362 equity Shares of face value of Rs 10 each). Powered by Capital Market - Live
This collaboration marks Antara's second project with Max Estates, following the highly successful Estate 360, Delhi-NCR's first intergenerational community. Estate 360 saw an overwhelming response, with 292 senior residences sold out within just 11 months. Estate 361, which has recently launched, will feature 360 senior living units and a state-of-the-art Integrated Wellness Centre. The wellness hub aims to combine modern healthcare with ancient Indian therapies, offering residents a holistic approach to well-being. The Antara Integrated Wellness Centre will provide a range of services, including primary healthcare with in-house doctors, 24x7 nursing, paramedics, emergency services, ambulance support, and specialist consultations. The centre will also offer wellness therapies such as Ayurveda, homeopathy, naturopathy, acupressure, acupuncture, and UV therapy. By integrating modern medicine with the time-tested benefits of traditional treatments, Antara plans to deliver proactive, preventive, and personalized care to seniors'ensuring their health and quality of life are continuously supported throughout their aging journey. Rajit Mehta, MD & CEO, Antara Senior Care, said, 'Ageing is a second coming of empowerment. It's a phase where seniors rediscover their aspirations and themselves. It's also a stage marked by increased need for physical, emotional and social wellbeing. With so many seniors navigating chronic conditions, mobility challenges and emotional vulnerability, wellbeing must be clinically guided, compassionate and woven into everyday life. Ageing actively calls for purpose designed communities. This is where intergenerational living embedded with integrated wellness can play an impactful role. Senior living models, like the one at Estate 361, can help India's ageing population stay active, engaged and confident for longer. At Antara, our mission is to build senior care ecosystems that bring all this together so seniors can age with dignity, ease and joy.' Max Financial Services is primarily engaged in the business of growing and nurturing business investments and providing management advisory services to group companies in India. The company's consolidated net profit tanked 96.3% to Rs 4.16 crore on 26.8% declined in revenue from operations to Rs 9,791.59 crore in Q2 FY26 over Q2 FY25. Shares of Max India rose 0.21% to Rs 193.35 on the BSE. Powered by Capital Market - Live
Antara Senior Care, part of the $7-billion Max Group operating a network of seven care homes nationally, has announced the launch of its new facility in Whitefield, Bengaluru. This 80-bed senior care home in Bengaluru's top IT hub and residential area strengthens the company's presence in Karnataka, where it now operates ~163 beds across Bannerghatta and Whitefield locations; nationally it now has 500 operational beds. The setup provides assisted living facility to meet seniors' short- to long-term needs and specialised transition care services through geriatric-trained teams and infrastructure designed to promote independence and check loneliness. Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 10.98%, vs industry avg of 15.81%
Over the last 5 years, market share decreased from 0.31% to 0.25%